Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Wilson

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Science Translational Medicine|August 10, 2022
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetesHiroki Kobayashi, Helen C Looker, Eiichiro Satake, et al.
Nature Medicine|April 24, 2019
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetesMonika A Niewczas, Meda E Pavkov, Jan Skupien, et al.
Journal of the American Society of Nephrology : JASN|June 18, 2021
Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in DiabetesEiichiro Satake, Pierre-Jean Saulnier, Hiroki Kobayashi, et al.
Conservation Physiology|October 22, 2016
Conservation physiology of marine fishes: state of the art and prospects for policyDavid J McKenzie, Michael Axelsson, Denis Chabot, et al.
Nature Communications|November 11, 2021
Elevated circulating follistatin associates with an increased risk of type 2 diabetesChuanyan Wu, Yan Borné, Rui Gao, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Science Translational Medicine|August 10, 2022
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetesHiroki Kobayashi, Helen C Looker, Eiichiro Satake, et al.
Nature Medicine|April 24, 2019
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetesMonika A Niewczas, Meda E Pavkov, Jan Skupien, et al.
Journal of the American Society of Nephrology : JASN|June 18, 2021
Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in DiabetesEiichiro Satake, Pierre-Jean Saulnier, Hiroki Kobayashi, et al.
Conservation Physiology|October 22, 2016
Conservation physiology of marine fishes: state of the art and prospects for policyDavid J McKenzie, Michael Axelsson, Denis Chabot, et al.
Nature Communications|November 11, 2021
Elevated circulating follistatin associates with an increased risk of type 2 diabetesChuanyan Wu, Yan Borné, Rui Gao, et al.
Pageof 12